Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India
- PMID: 37188018
- PMCID: PMC10180781
- DOI: 10.4103/ajts.ajts_103_21
Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India
Abstract
Background and objectives: High-yield plateletpheresis donations can reduce donor exposure and be economically beneficial as well. However, obtaining a high-yield plateletpheresis from a maximum number of donors with low basal platelet count and its effect on postdonation platelet count of donors undergoing high-yield plateletpheresis has been a matter of concern. This study aimed to assess the feasibility of making high-yield platelet donation as a routine practice.
Methods: It was a retrospective observational study to determine the effect of high-yield plateletpheresis on donor reactions, efficacy, and quality parameters. It was conducted from January 1, 2019 to June 30, 2021, at the Department of Transfusion Medicine in a tertiary care hospital of South India.
Results: Out of the 669 procedures, 564 (84.3%) of the collection had a platelet yield of ≥5 × 1011, 468 (70%) of the collection had a platelet yield of 5.5 × 1011, whereas 284 (42.5%) met the target of 6 × 1011 by coulter. The mean drops in platelet count were 95 ± 16 × 103/μl (77,600-113,000/μl), mean platelet recruitment was 1.31 ± 0.51. The mean collection efficiency of the procedure for the 669 cases was shown to be 80.21 ± 15.34, and the mean collection rate was 0.07 × 1011 ± 0.02 per minute. Only forty donors (5.5%) experienced adverse donor reactions.
Conclusions: High-yield plateletpheresis can be done in routine practice with no added adverse donor reaction with effective quality products.
Keywords: Donor reactions; Trima Accel; high-yield plateletpheresis; platelet yield.
Copyright: © 2022 Asian Journal of Transfusion Science.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Sahoo D, Mahapatra S, Parida P, Panigrahi R. Various aspects of plateletpheresis: Its impact on donor and patients. Glob J Transfus Med. 2017;2:149–54.
-
- Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, et al. Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial. Transfusion. 1999;39:674–81. - PubMed
-
- Chaudhary R, Das SS, Khetan D, Ojha S, Verma S. Donor safety issues in high-dose platelet collection using the latest apheresis systems. Transfus Altern Transfus Med. 2010;11:1–7.
LinkOut - more resources
Full Text Sources